The use of neoadjuvant larotrectinib in the management of children with locally advanced TRK fusion sarcomas. [electronic resource]
Producer: 20190917Description: 4241-4247 p. digitalISSN:- 1097-0142
- Child
- Child, Preschool
- Disease Progression
- Female
- Fibrosarcoma -- drug therapy
- Humans
- Infant
- Infant, Newborn
- Male
- Neoadjuvant Therapy
- Oncogene Proteins, Fusion -- genetics
- Pyrazoles -- therapeutic use
- Pyrimidines -- therapeutic use
- Receptor, trkA -- genetics
- Sarcoma -- drug therapy
- Soft Tissue Neoplasms -- drug therapy
- Treatment Outcome
No physical items for this record
Publication Type: Clinical Trial, Phase I; Clinical Trial, Phase II; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.